Teamwork Financial Advisors LLC Sells 25,886 Shares of Colgate-Palmolive (NYSE:CL)

Teamwork Financial Advisors LLC decreased its position in Colgate-Palmolive (NYSE:CL) by 83.3% during the 4th quarter, Holdings Channel reports. The firm owned 5,183 shares of the company’s stock after selling 25,886 shares during the period. Teamwork Financial Advisors LLC’s holdings in Colgate-Palmolive were worth $471,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Wesbanco Bank Inc. lifted its holdings in Colgate-Palmolive by 1.7% in the 4th quarter. Wesbanco Bank Inc. now owns 15,066 shares of the company’s stock worth $1,370,000 after buying an additional 250 shares during the period. Janney Montgomery Scott LLC lifted its stake in Colgate-Palmolive by 2.2% in the fourth quarter. Janney Montgomery Scott LLC now owns 387,487 shares of the company’s stock worth $35,227,000 after acquiring an additional 8,293 shares during the period. Atomi Financial Group Inc. raised its holdings in Colgate-Palmolive by 6.5% in the 4th quarter. Atomi Financial Group Inc. now owns 6,489 shares of the company’s stock worth $590,000 after purchasing an additional 394 shares in the last quarter. Crossmark Global Holdings Inc. lifted its position in shares of Colgate-Palmolive by 4.3% in the 4th quarter. Crossmark Global Holdings Inc. now owns 173,831 shares of the company’s stock worth $15,803,000 after purchasing an additional 7,105 shares during the period. Finally, Ballentine Partners LLC boosted its stake in shares of Colgate-Palmolive by 2.2% during the 4th quarter. Ballentine Partners LLC now owns 21,007 shares of the company’s stock valued at $1,910,000 after purchasing an additional 460 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.34% of the stock is currently owned by insiders.

Colgate-Palmolive Price Performance

CL stock opened at $87.53 on Thursday. Colgate-Palmolive has a 52-week low of $80.03 and a 52-week high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock has a market cap of $71.51 billion, a price-to-earnings ratio of 25.08, a price-to-earnings-growth ratio of 3.62 and a beta of 0.44. The business has a fifty day moving average of $92.00 and a two-hundred day moving average of $97.58.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CL. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. JPMorgan Chase & Co. lowered their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research report on Thursday, January 16th. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Piper Sandler reduced their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Finally, UBS Group cut their target price on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $101.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.